Medium Coronavirus Blog
A blog from Medium for Covid-19 news, advice, and commentary.

U.S. health officials raise concerns about the company’s latest efficacy data

In a highly unusual move, a U.S. health agency raised concerns on Tuesday that AstraZeneca had not provided the most current data about its Covid-19 vaccine in a press release it issued Monday.

In the release, which garnered excitement from public health experts, the company said its vaccine was 79%…

Hospitalized children with the inflammatory syndrome linked to Covid-19 have increased risk for acute kidney injury

For a while, early on in the pandemic, the world sighed with some relief at the apparent low risk the SARS-CoV-2 virus held for children. That sigh turned to an intake of breath with reports of a new syndrome emerging in children, apparently associated with the virus and often coming…

An OB-GYN reviews the latest coronavirus research for lactating people

Many new moms and lactating people are searching for definitive answers about the Covid-19 vaccine and breastfeeding. Considering more than 3.7 million individuals give birth in the United States per year, clear evidence-based guidelines are needed as soon as possible.

Nearly 110 million doses have been administered in the United…

Everything you need to know about the experimental drug molnupiravir

Vaccines are being rolled out across the country, but many are still at risk of infection with Covid-19. Though there are no drugs available to take at home yet, a pill for the coronavirus may be on the horizon.

An experimental drug meant to reduce the length of illness is…

Medium Coronavirus Blog

A blog from Medium for Covid-19 news, advice, and commentary.

Get the Medium app

A button that says 'Download on the App Store', and if clicked it will lead you to the iOS App store
A button that says 'Get it on, Google Play', and if clicked it will lead you to the Google Play store